Cargando…
B-Cells and Antibodies as Contributors to Effector Immune Responses in Tuberculosis
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is still a major threat to mankind, urgently requiring improved vaccination and therapeutic strategies to reduce TB-disease burden. Most present vaccination strategies mainly aim to induce cell-mediated immunity (CMI), yet a series of in...
Autores principales: | Rijnink, Willemijn F., Ottenhoff, Tom H.M., Joosten, Simone A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930078/ https://www.ncbi.nlm.nih.gov/pubmed/33679802 http://dx.doi.org/10.3389/fimmu.2021.640168 |
Ejemplares similares
-
Atypical Human Effector/Memory CD4(+) T Cells With a Naive-Like Phenotype
por: Caccamo, Nadia, et al.
Publicado: (2018) -
Antibody glycosylation in inflammation, disease and vaccination
por: Alter, Galit, et al.
Publicado: (2018) -
Innovative Strategies to Identify M. tuberculosis Antigens and Epitopes Using Genome-Wide Analyses
por: Geluk, Annemieke, et al.
Publicado: (2014) -
Tuberculosis Biomarkers: From Diagnosis to Protection
por: Goletti, Delia, et al.
Publicado: (2016) -
HIV-Infected Patients Developing Tuberculosis Disease Show Early Changes in the Immune Response to Novel Mycobacterium tuberculosis Antigens
por: Meier, Noemi Rebecca, et al.
Publicado: (2021)